COMP <GO>
PARK vs MGRX // OPERATING MARGIN
Park Dental Partners Inc. (NASDAQ) VS. Mangoceuticals Inc. (NASDAQ) • 15-METRIC TALLY: PARK 2
— MGRX 0
■ METRIC PARITY
LAST: $20.06 (-2.79%) • MKT CAP: $95.4M
operating-margins
—
LAST: $0.25 (-1.47%) • MKT CAP: $5.7M
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PARK VS. MGRX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PARK | MGRX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 54.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -26.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.0 | 36.8 | +13.20 | PARK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.4M | $5.7M | $89.7M | PARK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PARK REV | MGRX REV | PARK GROSS % | MGRX GROSS % | PARK FCF | MGRX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $456.0K | — | 54.9% | — | -$5.9M |
| FY 2024 | — | $615.9K | — | 61.7% | — | -$4.9M |
| FY 2023 | — | $731.5K | — | — | — | -$7.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PARK // BETA —
MGRX // BETA —